Laboratory and semi-field evaluation of Bacillus thuringiensis (Bioflash®) against Anopheles stephensi (Diptera: Culicidae) in an endemic malarious area of Iran


1 Master of Science in Medical Entomology, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 Associate Professor, Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

3 Associate Professor, Research Center for Health Sciences, Institute of Health, Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran


Background: Anopheles stephensi is considered to be the main malaria vector in the Middle East area including Iran. We aimed to evaluate the efficiency of a granule 10% formulation of Bacillus thuringiensis against this species under laboratory and semi-field conditions in an endemic malarious area of Iran.
Method: After collecting mosquitos from Hurmudar, in order to find the best effective dose, five dosages (a quarter-dose, half dose, recommended dose, a twice-dose and four times dose) were used for laboratory and semi-field assays in Bandar Abbas.
Results: Recommended dose by factory (0.017 g /0.1 m2) showed the highest mortality rate on An. stephensi larvae in both assays. The efficiency of Bt was very low (21 %) under semi-field condition. According to the results of this study, the use of bacteria alone cannot be a useful and effective way to control the vector of malaria in Iran's geographic conditions. Conclusion: This method can be used (in the case of appropriate efficacy of the tested formulation in field condition) as one of the constituent parts of Integrated Vector Management (IVM) program along with other recommended methods.


  1. Kalantari M, Soltani Z, Ebrahimi M, Yousefi M, Amin M, Shafiei A, et al. Monitoring of Plasmodium infection in humans and potential vectors of malaria in a newly emerged focus in southern Iran. Pathog Glob Health 2017; 111(1):49-55.
  2. Soltani A, Vatandoost H, Jabbari H, Mesdaghinia AR, Mahvi AH, Younesian M, et al. Field efficacy of expanded polystyrene and shredded waste polystyrene beads for mosquito control in artificial pools and field trials, Islamic Republic of Iran. East Mediterr Health J 2012; 18(10):1042-8.
  3. Turki H, Soltani A. Semi-field and field studies on the efficacy of monomolecular surface film (Agnique®) against immature mosquitoes in the malarious areas of Iran. Asian Pac J Trop Dis 2017; 7(8):472-6.
  4. Hanafi-Bojd AA, Vatandoost H, Oshaghi MA, Haghdoost AA, Shahi M, Sedaghat MM, et al. Entomological and epidemiological attributes for malaria transmission and implementation of vector control in southern Iran. Acta Trop 2012; 121(2):85-92.
  5. Soltani A, Vatandoost H, Oshaghi MA, Enayati AA, Chavshin AR. The role of midgut symbiotic bacteria in resistance of Anopheles stephensi (Diptera: Culicidae) to organophosphate insecticides. Pathogens and global health. 2017 Aug 18; 111(6):289-96.
  6. World Health Organization (WHO). World malaria report 2018. [cited 2019 Apr 14] Available from:
  7. Gezelbash Z, Vatandoost H, Abai MR, Raeisi A, Rassi Y, Hanafi Bojd AA, et al. Laboratory and field evaluation of two formulations of Bacillus thuringiensis MH-14 against mosquito larvae in the Islamic Republic of Iran, 2012. Eastern Mediterranean Health Journal 2014; 20 (‎4)‎:229-35.
  8. Shahi M, Hanafi-Bojd A, Vatandoost H, Soleimani Ahmadi M. Susceptibility status of Anopheles stephensi Liston the main malaria vector, to deltamethrin and Bacillus thuringiensis in the endemic malarious area of Hormozgan province, Southern Iran. Journal of Kerman University of Medical Sciences 2012; 19(1):87-95. [In Persian].
  9. Shahi M, Kamrani E, Salehi M, Habibi R, Hanafi-Bojd AA. Native larvivorous fish in an endemic malarious area of southern Iran, a biological alternative factor for chemical larvicides in malaria control program. Iran J Public Health 2015; 44(11):1544-9.
  10. Uragayala S, Kamaraju R, Tiwari S, Ghosh SK, Valecha N. Field testing & evaluation of the efficacy & duration of effectiveness of a biolarvicide, Bactivec® SC (Bacillus thuringiensis var. israelensis SH-14) in Bengaluru, India. Indian J Med Res 2018; 147(3):299-307.
  11. Sanahuja G, Banakar R, Twyman RM, Capell T, Christou P. Bacillus thuringiensis: a century of research, development and commercial applications. Plant Biotechnol J 2011; 9(3):283-300.
  12. Fillinger U, Knols BG, Becker N. Efficacy and efficiency of new Bacillus thuringiensis var. israelensis and Bacillus sphaericus formulations against Afrotropical anophelines in Western Kenya. Trop Med Int Health 2003; 8(1):37-47.
  13. Becker N, Rettich F. Protocol for the introduction of new Bacillus thuringiensis israelensis products into the routine mosquito control program in Germany. J Am Mosq Control Assoc 1994; 10(4):527-33.
  14. Kroeger A, Horstick O, Riedl C, Kaiser A, Becker N. The potential for malaria control with the biological larvicide Bacillus thuringiensis israelensis (Bti) in Peru and Ecuador. Acta Trop 1995; 60(1):47-57.
  15. Majori G, Ali A, Sabatinelli G. Laboratory and field efficacy of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus against Anopheles gambiae sl and Culex quinquefasciatus in Ouagadougou, Burkina Faso. J Am Mosq Control Assoc 1987; 3(1):20-5.
  16. Shililu JI, Tewolde GM, Brantly E, Githure JI, Mbogo CM, Beier JC, et al. Efficacy of Bacillus thuringiensis israelensis, Bacillus sphaericus and temephos for managing Anopheles larvae in Eritrea. J Am Mosq Control Assoc 2003; 19(3):251-8.
  17. Begum M, Akbar H, Saha ML, Khan HR. Efficacy of Bacillus thuringiensis var. israelensis against the larvae of Aedes aegypti. j Asiat Soc Bangladesh 2015; 41(1):33-44.
  18. Perich MJ, Rogers JT, Boobar LR. Efficacy of Arosurf MSF and formulations of Bacillus thuringiensis var. israelensis against Anopheles albimanus: laboratory bioassay. J Am Mosq Control Assoc 1987; 3(3):485-8.